Work

Phase I study of high-dose interleukin 2, aldesleukin, in combination with the histone deacetylase inhibitor, entinostat, in patients with metastatic renal cell carcinoma: Safety and tolerability results.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.6_suppl.369

Authors: Roberto Pili, Li Shen, Saby George, Hans J. Hammers, Anita Sandecki, Connie Collins, Michael Anthony Carducci

Institutions: Roswell Park Comprehensive Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590243760

Cites:

Cited by: 2

Related to: 10